NEC OncoImmunity AS
Oslo
About NEC OncoImmunity AS
NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning based software, which addresses the key knowledge gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.4M
- Funding stage: M&A
- Last round: Seed (Apr 2022)
- Website: oncoimmunity.com
- Phone: 47 90 01 52 42
Industries & Categories
Artificial Intelligence (AI), Bioinformatics, Biotechnology, Health Care, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/nec-oncoimmunity-as-3142 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.